CompletedNCT00237848
D-serine added to cognitive training for schizophrenia
About this title
D-Serine for Enhancing Cognitive Retraining for the Treatment of Schizophrenia
Read the official source — NCT00237848Medication studyAges 18–65India
Understand this study
Who was this study for?
This study was for people with schizophrenia. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
- Listed locations
- BangaloreSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateFebruary 2005
- Recruitment status
- Completed
- Enrollment listed in the registry
- 72
- Sponsor
- Yale University
- Sponsor type
- University
- Study type
- Behavioral
- Intervention type
- Psychotherapy / behavioral intervention, Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- India
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00237848
- Official title
Show the full official title
D-Serine Augmentation of Cognitive Retraining in Schizophrenia
Get this study by email
Recruitment & locations
CompletedBangalore
Questions about this study
Who is behind this study?
The study sponsor is Yale University, a university.
Did this study involve medication?
Yes. The study involved medication, including D-serine.
Who was this study for?
This study was for people with schizophrenia. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
Want to explore more studies?
Explore studiesRelated studies
Effectiveness of a Problem-solving Intervention for Common Adolescent Mental Health Problems in India
Study on Examination of Therapeutic Efficacy and Potential Mechanisms of Yoga Treatment in Schizophrenia
